<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/254830-compounds-as-glucagon-receptor-antagonists by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 11:14:56 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 254830:&quot;COMPOUNDS AS GLUCAGON RECEPTOR ANTAGONISTS&quot;</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">&quot;COMPOUNDS AS GLUCAGON RECEPTOR ANTAGONISTS&quot;</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagons receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagons related metabolic disorders, and the like.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>The invention relates to compounds that are antagonists or inverse agonists of the glucagon receptor, and to pharmaccutial compositions in the treatment of the human or animal body......................<br><br><br><br><br><br><br>
WE CLAIM:<br>
1. A compound structurally represented by Formula 1<br>
(Formula Removed)<br>
(I) or a pharmaceutically acceptable salt thereof wherein: Rl and R2 are independently -H or -halogen; R3 is<br>
~(C1-C8) alkyl(optionally substituted with 1 to 3 halogens),<br>
-(C3-C7)cycloalkyl, -(C1-C6)alkvl-(C3-C7)cycloalkyl, or<br>
-(C3-C7)cycloalkyl-(C1-C6)alkyl(optionally substituted with 1 to 3 halogens); R4 and R5 are independently<br>
-H, -halogen, -hydroxy, hydroxymethyl, -CN, -(C1-C7) alkoxy, -(C2- C7)alkenyl, or -(C1-C6)alkyl (optionally substituted with 1 to 3 halogens); R6 is<br>
(Formula Removed)<br>
wherein the zig-zag mark shows the point of attachment to the parent molecule;<br>
R7 and R8 are independently<br>
-H, -halogen, -(C1-C6)alkyl(optionally substituted with 1 to 3 halogens),<br>
-(C1-C6)alkoxy, -(C3-C7)cyeloalkyl, -C(O)R10) -COOR10, -OC(O)R10,-OS(O)2R10, -SR10,<br>
-<br>
S(O)R10, -S(O);R10, or -O(C2-C7)alkenyl; R9 is independently<br>
-II, -halogen, -CN, -(G-G)cycloalkyl, -C(O)R10, -COOR10, -OC(O)R10,<br>
-OS(O)2R10, -SR10, -S(O)Rl0, -S(O)2R10, or -O(C2-C7)alkenyl,<br>
-(C1-C3)alkoxy(optionallv substituted with 1 to 3 halogens), or<br>
-(C1-C6) alkyl (optionally substituted with 1 to 3 halogens); and<br>
R10 is independently at each occurrence<br>
-hydrogen, or -(C1-C6) alkyl(optionallv substituted with 1 to 3 halogens).<br>
2.  The compound as claimed in claim 1, or a pharmaceuticallv acceptable salt thereof, wherein Rl and R2 are -H;<br>
R3 is<br>
-(C1-C8) alkyl(optionallv substituted with 1 to 3 halogens),<br>
-(C3-C6)cycloalkyl, -(C1-C6)alkyl-(C3-C6)cycloalkyl, or -(C3-C6)cycloalkyl-(C1-<br>
C6)alkyl(optionally substituted with 1 to 3 halogens);<br>
R4 and R5 are independently<br>
-H, -halogen, or -(C1-C6)alkyl (optionally substituted with 1 to 3 halogens); R6 is<br>
(Formula Removed)<br>
wherein the zig-zag mark shows the point of attachment to the parent molecule;<br>
R7 and R8 are independently<br>
-H, -halogen, -(C1-C3)alkyl(optionally substituted with 1 to 3 halogens), or -(C1-C3alkoxy; and<br>
R9 is independently<br>
-H, -halogen, or -(C1-C6) alkvl (optionally substituted with 1 to 3 halogens).<br>
3. The compound as claimed in claim 1, or a pharmaceutically acceptable salt thereof, wherein Rl and R2 are -H;<br>
R3 is<br>
-(C1-C8) alkyl(optionally substituted with 1 to 3 halogens),<br>
-(C3-C6)cycloalkyl, -( C1-C6)alkyl-(C3-C6)cycloalkyl, or<br>
-(C3-C6,)cyeloalkyl-( C1-C6)alkyl(optionallv substituted with 1 to 3 halogens);<br>
R4 and R5 are independently<br>
-H, -halogen, or -CH-, (optionally substituted with 1 to 3 halogens);<br>
R6 is<br>
(Formula Removed)<br>
wherein the zig-zag mark shows the point of attachment to the parent molecule;<br>
R7 and R8 are independently -I I, or -halogen; and<br>
R9 is independently -(G-G) alkyl (optionally substituted with 1 to 3 halogens).<br>
4.	The compound as claimed in claim 1, or a pharmaceutically acceptable salt thereof,<br>
wherein Rl and R2 are -H; R3 is -(C4-C8) alkyl(optionally substituted with 1 to 3<br>
halogens), -(C3,-C6)cycloalkvl, -(C1-C6)alkvl-(C3-C6)cycloalkyl, or -(C3-C6)evcloalkyl-(C1-<br>
C6,)alkyl(optionally substituted with 1 to 3 halogens); R4 and R5 are -CH3; (optionally<br>
substituted with 1 to 3 halogens) and each occupies a position adjacent to R6 on the<br>
phenyl ring to which R6 is attached;<br>
R6 is<br>
(Formula Removed)<br>
wherein the zig-zag mark shows the point of attachment to the parent molecule;<br>
R7 and R8 are -H; and R9 is independently -(G-G,) alkyl (optionally substituted with 1 to 3 halogens).<br>
5.	The compound as claimed in claim 1, or a pharmaceutically acceptable salt thereof, wherein Rl and R2 are independently hydrogen or halogen; R3 is methyl, ethyl, propyl, isopropyl, butyl, pentvl, hexyl, heptyl, octyl, 3,3-dimethylbutyl, 2-methylpropyl, 3 -methyl-butyl, tertbutyl, 4-methylpentyl, 2,2-dimethvlpropyl, 3,3,3- trifluoropropyl, 4,4,4-trifluorbutyl, cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexvl; R4 and R5 are independently   hydrogen,   methyl,   ethyl,   tertbutyl,   cyclohexvl,   pentvl,   isopropoxy,<br><br>
chloro, t'luoro, bromo, hvdoxv, trifluoromethyl - CN, methoxy, hydroxymethyl, 4-methylpentyloxy, or pentvloxy; R7 and R8 are independently hydrogen, fluoro, chloro, methyl, ethyl, pentyl, isopropyl, tertbutyl, trifluoromethyl, acetyl, 2-methylpropvl, methoxy, cyclohexyl, or Irifluormethoxv; and R9 is hydrogen, bromo, fluoro, methyl, tertbutyl, trifluoromethyl, or isopropyl.<br>
6. The compound as claimed in claim 1, selected from the group consisting of formulae XI to XII<br>
(Table Removed)<br>
or a pharmaceutically acceptable salt thereof.<br>
7. The compound as calimed in claim 1 selected from the group consisting of:<br>
(R3)-5-[l-(4'-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-2-methyl-propyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[ 1 -(4'-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-propyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(4'-tert-Butyl-2,6-dimothyl-biphenyl-4-ylsulfanyl)butyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide;<br>
(+)-5-[1-(4!-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-pentyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(4'-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-3-methyl-butyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide;<br>
((±)-5-[l-(4'-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-3,3-dimethyl-butyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(4'-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-2,2-dimethyl-propyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(2,5-Dimethyl-4,-trifluoromethyl-biphenyl-4-ylsulfanyl)-butyl]- thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-2-methyl- propyl]-thiophene-2-carboxylic acid (lH-tetrazol-5-ylmethyl)-amide;<br>
(±)-541-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-2,2-dimethyl-propy]]-thiophene-2-carboxvlic acid (lH-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(2,6-Dimethyl-4'-trifluoromethyl-bipbenyl-4-ylsulfanyl)-3-methyl-butyl]-thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(2,6-Dimelhyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-3,3-dimethyl-butyl]-thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide;<br>
(±)-5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-pentyl]- thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide;<br>
5-[l-(4'-tert-Butyl-2,6-dimethyl-biphhenyl-4-ylsulfanyl)-2,2-dimethyl-propyl]- tbiophene-2-earboxylie acid (2H-tetrazol-5-vlmetbyl)-amide (Isomer 1);<br>
5-[l-(4'-tert-Butyl-2,5-dimethyl-biphenyl-4-ylsulfanyl)-2,2-dimethyl-propyl]- thiopbene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide (Isomer T);<br>
5-[1-(4,-tert-Butyl-2H-dimethyl-biphenyl-4-ylsulfanyl)-propyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide (Isomer 1);<br>
5-[l-(4'-tert-Butyl-2,6-dimethyl-bipbenyl-4-ylsulfanyl)-propyl]-thiophone-2- carboxylic-add (2H-tetrazol-5-ylmetbyl)-amide (Isomer 2);<br>
5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-butyl]-thiophene-2-carboxvlic acid (lH-tetrazol-5-ylmethyl)-amide (Isomer 1);<br>
5-[1-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-butyl]-thiophene-2-<br>
carboxylic acid (1H-tetrazol-5-ylmethyl)-amide (Isomer 2);<br>
5-[1-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-2-methyl-propyl]-thiophene-2-carboxvlic acid (1H-terrazol-5-ylmethyl)-amide (Isomer 1);<br>
5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-2-methyl-propyl]-thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide (Isomer 2);<br>
5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-2,2-dimethyl- propyl]-thiophene-2-carboxylic acid (lH-tetrazol-5-vlmethyl)-amideb (Isomer 1);<br>
5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-2,2-dimethyl- propyl]-thiophene-2-carboxvlic acid (1H-tetrazol-5-vlmethyl)-amideb (Isomer 2);<br>
5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-3-methyl-butyl]- tbiophene-2-carboxylic acid (lH-tetrazol-5-ylmethyl)-amide (Isomer 1); 5-[l-(2,6-Dimetbyl-4'-trifluoromethyl-biphenyl-4-ylsulfanyl)-3-methyl-butyl]- thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide (Isomer 2);<br>
5-[l-(2,6-Dimethyl-4'-trifluorometbyI-bipbenyl-4-ylsulfanyl)-3,3-dimethyl-butyl]-thiophene-2-carboxylic acid (II I-tetrazol-5-ylmetbvl)-amide (Isomer 1);<br>
5-[l -(2,6-Dimethyl-4'-trifluorometthyl-biphenyl-4-ylsulfanyl)-3,3-dimethyl-butyl]-<br>
thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide (Isomer 2);<br>
5-[l-(2,6-Dimethyl-4'-trifluorometby]-biphonyl-4-ylsulfanyl)-pentyl]-thiophene-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide (Isomer 1); and<br>
5-[l-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-ylsulfanvl)-pontyl]-thiophone-2-carboxylic acid (1H-tetrazol-5-ylmethyl)-amide (Isomer 2);<br>
or a pharmaceutically acceptable salt thereof.<br>
8.	A pharmaceutical composition comprising a compound of any of claims 1-7 and a<br>
pharmaceutically acceptable carrier.<br>
9.	A compound or a salt thereof, as claimed in anv one of claims 1-7 for use in treating a diabetic or other glucagon related metabolic disorder for the manufacture of a medicament thereof.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUFic3RyYWN0LSgyNy0wMy0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Abstract-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUFzc2lnbm1lbnQtKDI3LTAzLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Assignment-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUNsYWltcy0oMTAtMDctMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Claims-(10-07-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUNsYWltcy0oMjctMDMtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Claims-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUNvcnJlc3BvbmRlbmNlIE90aGVycy0oMTAtMDctMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Correspondence Others-(10-07-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LUNvcnJlc3BvbmRlbmNlIE90aGVycy0oMTktMTAtMjAxMSkucGRm" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-Correspondence Others-(19-10-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUNvcnJlc3BvbmRlbmNlIE90aGVycy0oMjctMDMtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Correspondence Others-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LWNvcnJlc3BvbmRlbmNlLW90aGVycyAoMTItMDUtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-correspondence-others (12-05-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LUZvcm0tMSAoMDYtMDUtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-Form-1 (06-05-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUZvcm0tMS0oMjctMDMtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Form-1-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LUZvcm0tMTMgKDEyLTA1LTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-Form-13 (12-05-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LWZvcm0tMTggKDEyLTA1LTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-form-18 (12-05-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUZvcm0tMi0oMjctMDMtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Form-2-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LUZvcm0tMyAoMDMtMTAtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-Form-3 (03-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUZvcm0tMy0oMjctMDMtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Form-3-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LUdQQSAoMDYtMDUtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-GPA (06-05-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LUdQQS0oMTAtMDctMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-GPA-(10-07-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1kZWxucC0yMDA4LUdQQS0oMTktMTAtMjAxMSkucGRm" target="_blank" style="word-wrap:break-word;">3841-delnp-2008-GPA-(19-10-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Mzg0MS1ERUxOUC0yMDA4LVBldGl0aW9uLTEzNy0oMjctMDMtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">3841-DELNP-2008-Petition-137-(27-03-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Rm9ybS0xLnBkZg==" target="_blank" style="word-wrap:break-word;">Form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Rm9ybS0zLnBkZg==" target="_blank" style="word-wrap:break-word;">Form-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=Rm9ybS01LnBkZg==" target="_blank" style="word-wrap:break-word;">Form-5.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="254829-an-electric-switch-in-a-sealed-housing-filled-with-an-insulating-liqued-to-reduce-aging-of-the-switching-oil.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="254831-a-circuit-breaker-pole-insulated-by-solid-material.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>254830</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>3841/DELNP/2008</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>52/2012</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>28-Dec-2012</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>24-Dec-2012</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>06-May-2008</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>ELI LILLY AND COMPANY</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>Lilly Corporate Center Indianapolis IN 46285 USA</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>CHAPPELL, Mark, Donald</td>
											<td>541 Pitney Drive Noblesville Indiana 46062 US;</td>
										</tr>
										<tr>
											<td>2</td>
											<td>CONNER, Scott, Eugene</td>
											<td>8426 Carefree Circle  Indianapolis  Indiana 46236  US</td>
										</tr>
										<tr>
											<td>3</td>
											<td>HIPSKIND, Philip, Arthur</td>
											<td>4255 Cabin Court  New Palestine  Indiana 46163  US;</td>
										</tr>
										<tr>
											<td>4</td>
											<td>TRIPP, Allie, Edward</td>
											<td>219 Byrkit Street  Indianapolis  Indiana 46217  US;</td>
										</tr>
										<tr>
											<td>5</td>
											<td>ZHU, Guoxin</td>
											<td>21F  1 Corporate Avenue  No.222  Hu Bin Road  Shanghai 200021 CN;</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D 409/12</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/US2006/061132</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2006-11-21</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>60/739,692</td>
									<td>2005-11-23</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/254830-compounds-as-glucagon-receptor-antagonists by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 11:14:57 GMT -->
</html>
